Osteosarcoma ... reactive oxygen species and nitrogen to enhance anti-tumor activity, Albert et al. prepared HA and alginate hydrogels for the treatment of osteosarcoma (Espona-Noguera et al., 2024).

The immunosuppressive microenvironment in osteosarcoma is the main reason for the ineffectiveness of immunotherapy, in which the low immune response rate of immune effector cells and the high ...

New research, published in the journal Cell, solves the mystery of what drives the genomic rearrangements causing the aggressive development and evolution of osteosarcoma tumours. By analysing the ...

Researchers published a new study, “Ongoing chromothripsis underpins osteosarcoma genome complexity and clonal evolution,” in Cell that they say solves the mystery of what drives the genomic ...